| Autor: |
Hendricks PS; 1 Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, USA., Crawford MS; 1 Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, USA., Cropsey KL; 2 Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, USA., Copes H; 3 Department of Criminal Justice, University of Alabama at Birmingham, Birmingham, USA., Sweat NW; 1 Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, USA., Walsh Z; 4 Department of Psychology, University of British Columbia, Kelowna, Canada., Pavela G; 1 Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, USA. |
| Abstrakt: |
Criminal behavior exacts a large toll on society and is resistant to intervention. Some evidence suggests classic psychedelics may inhibit criminal behavior, but the extent of these effects has not been comprehensively explored. In this study, we tested the relationships of classic psychedelic use and psilocybin use per se with criminal behavior among over 480,000 United States adult respondents pooled from the last 13 available years of the National Survey on Drug Use and Health (2002 through 2014) while controlling for numerous covariates. Lifetime classic psychedelic use was associated with a reduced odds of past year larceny/theft (aOR = 0.73 (0.65-0.83)), past year assault (aOR = 0.88 (0.80-0.97)), past year arrest for a property crime (aOR = 0.78 (0.65-0.95)), and past year arrest for a violent crime (aOR = 0.82 (0.70-0.97)). In contrast, lifetime illicit use of other drugs was, by and large, associated with an increased odds of these outcomes. Lifetime classic psychedelic use, like lifetime illicit use of almost all other substances, was associated with an increased odds of past year drug distribution. Results were consistent with a protective effect of psilocybin for antisocial criminal behavior. These findings contribute to a compelling rationale for the initiation of clinical research with classic psychedelics, including psilocybin, in forensic settings. |
